US Patent Issued to The Schepens Eye Research Institute on Sept. 8 for "Methods and compositions for the treatment of corneal endothelium disorders" (Massachusetts Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,118, issued on Sept. 8, was assigned to The Schepens Eye Research Institute Inc. (Boston).

"Methods and compositions for the treatment of corneal endothelium disorders" was invented by Ula Jurkunas (Winchester, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This application discloses methods and pharmaceutical compositions (e.g., oral, parenteral or topical ophthalmic formulations) for treating Fuchs endothelial corneal dystrophy (FECD)."

The patent was filed on Dec. 22, 2021, under Application No. 18/267,905.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sec...